Article Details
Retrieved on: 2022-04-25 21:58:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has filed a Biologics Licensing Application (BLA) with the U.S. Food and Drug Administration for tremelimumab, hoping to expand ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here